The DOI matches its Crossref record.
Both ETA and ETB receptors mediate contraction to endothelin-1 in human blood vessels.
Abstract
BACKGROUND: Endothelin (ET)-1 has potent vascular effects. Two endothelin receptors have been cloned, namely, the ETA receptor, which preferentially binds ET-1, and the ETB receptor, which equally binds ET-1 and ET-3 and preferentially sarafotoxin S6c. We characterized endothelin receptor subtypes on vascular smooth muscle and endothelium of isolated human internal mammary artery (IMA) and vein (IMV) and porcine coronary artery (PCA) using the ETA antagonists FR139317 and BQ-123, the ETB ligand sarafotoxin S6c, and the ETA/ETB antagonist Ro 47-0203 (bosentan). METHODS AND RESULTS: In endothelium-denuded IMA and PCA and less so in IMV, FR139317 and BQ-123 (in PCA only) shifted the concentration-contraction curves to ET-1 parallel to the right. However, even at 10(-5) mol/L, FR139317 did not inhibit a high-sensitivity portion of the concentration-contraction curve. Moreover, the ETB receptor agonist sarafotoxin S6c induced contraction in vessels preincubated with FR139317. IMV was significantly more sensitive to the contractile effect of ET-1 and sarafotoxin S6c than was IMA (P < .05). Prolonged incubation with sarafotoxin S6c (to downregulate ETB receptors) and FR139317 eliminated the contraction resistant to FR139317. The ETA/ETB receptor antagonist bosentan caused a parallel shift of the concentration-contraction curve to the right at all concentrations of endothelin. ETB receptor mRNA was detected by Northern blot analysis in IMA and aortic smooth muscle cells. In precontracted IMA and PCA with endothelium, sarafotoxin S6c did not cause endothelium-dependent relaxations, whereas transient responses occurred in IMV. CONCLUSIONS: Vascular smooth muscle cells of human IMA, IMV, and PCA contain both ETA and ETB receptors, whereas the endothelium of IMA and PCA does not express functional ETB receptors linked to nitric oxide and/or prostacyclin production. Hence, inhibition of endothelin-induced contraction in patients requires the use of combined ETA/ETB antagonists.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cited by
Hypoxic Pulmonary Vasoconstriction
Sylvester, J. T., Shimoda, L. A., Aaronson, P. I., & Ward, J. P. T. (2012) · Physiological Reviews · doi:10.1152/physrev.00041.2010 · Cited by 725
Levin, E. R. (1995) · New England Journal of Medicine · doi:10.1056/nejm199508103330607 · Cited by 711
Lüscher, T. F., & Barton, M. (2000) · Circulation · doi:10.1161/01.cir.102.19.2434 · Cited by 596
Evidence for endothelin-1-mediated vasoconstriction in severe chronic heart failure
Kiowski, W., Kim, J., Oechslin, E., Sütsch, G., Hunziker, P., Müller, P., Bertel, O., Schmitt, R., & Jones, R. (1995) · The Lancet · doi:10.1016/s0140-6736(95)91504-4 · Cited by 571
Pathophysiology of contrast medium–induced nephropathy
Persson, P. B., Hansell, P., & Liss, P. (2005) · Kidney International · doi:10.1111/j.1523-1755.2005.00377.x · Cited by 544
The endothelin system in pulmonary arterial hypertension
GALIE, N. (2004) · Cardiovascular Research · doi:10.1016/j.cardiores.2003.11.026 · Cited by 515
Ambrisentan Therapy for Pulmonary Arterial Hypertension
Galié, N., Badesch, D., Oudiz, R., Simonneau, G., McGoon, M. D., Keogh, A. M., Frost, A. E., Zwicke, D., Naeije, R., Shapiro, S., et al. (2005) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2005.04.050 · Cited by 494
Verhaar, M. C., Strachan, F. E., Newby, D. E., Cruden, N. L., Koomans, H. A., Rabelink, T. J., & Webb, D. J. (1998) · Circulation · doi:10.1161/01.cir.97.8.752 · Cited by 453
Mulder, P., Richard, V., Derumeaux, G., Hogie, M., Henry, J. P., Lallemand, F., Compagnon, P., Macé, B., Comoy, E., Letac, B., et al. (1997) · Circulation · doi:10.1161/01.cir.96.6.1976 · Cited by 360
Anand, I., McMurray, J., Cohn, J. N., Konstam, M. A., Notter, T., Quitzau, K., Ruschitzka, F., & Lüscher, T. F. (2004) · The Lancet · doi:10.1016/s0140-6736(04)16723-8 · Cited by 347
Self-citationHaynes, W. G., Ferro, C. J., O’Kane, K. P. J., Somerville, D., Lomax, C. C., & Webb, D. J. (1996) · Circulation · doi:10.1161/01.cir.93.10.1860 · Cited by 318
Insulin Stimulates Both Endothelin and Nitric Oxide Activity in the Human Forearm
Cardillo, C., Nambi, S. S., Kilcoyne, C. M., Choucair, W. K., Katz, A., Quon, M. J., & Panza, J. A. (1999) · Circulation · doi:10.1161/01.cir.100.8.820 · Cited by 301
Sütsch, G., Kiowski, W., Yan, X.-W., Hunziker, P., Christen, S., Strobel, W., Kim, J.-H., Rickenbacher, P., & Bertel, O. (1998) · Circulation · doi:10.1161/01.cir.98.21.2262 · Cited by 287
Role of Endothelin in the Increased Vascular Tone of Patients With Essential Hypertension
Cardillo, C., Kilcoyne, C. M., Waclawiw, M., Cannon, R. O., & Panza, J. A. (1999) · Hypertension · doi:10.1161/01.hyp.33.2.753 · Cited by 285
Different Mechanisms of Endothelial Dysfunction With Aging and Hypertension in Rat Aorta
Küng, C. F., & Lüscher, T. F. (1995) · Hypertension · doi:10.1161/01.hyp.25.2.194 · Cited by 282
Haynes, W. G., Strachan, F. E., & Webb, D. J. (1995) · Circulation · doi:10.1161/01.cir.92.3.357 · Cited by 279
Matrix Metalloproteinases in Normal Pregnancy and Preeclampsia
Chen, J., & Khalil, R. A. (2017) · Progress in Molecular Biology and Translational Science · doi:10.1016/bs.pmbts.2017.04.001 · Cited by 274
Increased Activity of Endogenous Endothelin in Patients With Type II Diabetes Mellitus
Cardillo, C., Campia, U., Bryant, M. B., & Panza, J. A. (2002) · Circulation · doi:10.1161/01.cir.0000032260.01569.64 · Cited by 259
Association Between Sleep Apnea and Blood Pressure Control Among Blacks: Jackson Heart Sleep Study
Johnson, D. A., Thomas, S. J., Abdalla, M., Guo, N., Yano, Y., Rueschman, M., Tanner, R. M., Mittleman, M. A., Calhoun, D. A., Wilson, J. G., et al. (2019) · Circulation · doi:10.1161/circulationaha.118.036675 · Cited by 81
Metadata
- Authors
- Seo, B., Oemar, B. S., Siebenmann, R., von Segesser, L., & Lüscher, T. F.
- Venue
- Circulation
- Published
- 1994-03
- Volume
- 89
- Issue
- 3
- Pages
- 1203-1208
- ISSN
- 0009-7322 (ISSN-L)
- 1524-4539
- OpenAlex
- W2001252757
- Cited by
- 517
- References
- 0
- FWCI
- 23.91
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.